Toll-like receptor 3 is critical for coxsackievirus b4-induced type 1 diabetes in female nod mice

Endocrinology (United States)

Volumn 156, Issue 2, 2015, Pages 453-461

  McCall, Kelly D ^a   Thuma, Jean R ^a   Courreges, Maria C ^a   Benencia, Fabian ^a   James, Calvin B L ^b   Malgor, Ramiro ^c   Kantake, Noriko ^a   Mudd, William ^a   Denlinger, Nathan ^b   Nolan, Bret ^a   Wen, Li ^c   Schwartz, Frank L ^a  

^a OHIO UNIVERSITY   (United States)

^b US Institute of Navigation   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INSULIN; TOLL LIKE RECEPTOR 3; TLR3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIE VIRUS INFECTION; DIABETOGENESIS; DISEASE DURATION; DISEASE SEVERITY; EMBRYO; FEMALE; GENE SILENCING; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREATITIS; PRIORITY JOURNAL; SCORING SYSTEM; T LYMPHOCYTE; TIME; VIRUS ACTIVATION; WILD TYPE; ANIMAL; COMPLICATION; ENTEROVIRUS B; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; METABOLISM; PANCREAS; RANDOMIZATION; VIROLOGY;

ANIMALS; COXSACKIEVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; FEMALE; MICE, INBRED NOD; MICE, KNOCKOUT; PANCREAS; RANDOM ALLOCATION; TOLL-LIKE RECEPTOR 3;

EID: 84921646418     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2006     Document Type: Article

References (65)

1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221-229
2. Bach JF. Predictive medicine in autoimmune diseases: from the iDentification of genetic predisposition and environmental influence to precocious immunotherapy. Clin Immunol Immunopathol. 1994; 72:156-161
3. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51:3353-3361
4. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-DepenDent) and type 2 (non-insulin-DepenDent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992;35:1060-1067
5. Banatvala JE, Bryant J, Schernthaner G, et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-DepenDent diabetes mellitus in Britain, Austria, and Australia. Lancet. 1985;1:1409-1412
6. Horwitz MS, Ilic A, Fine C, Balasa B, Sarvetnick N. Coxsackieviralmediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of cells. Clin Immunol. 2004;110: 134-144
7. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystanDer damage and not molecular mimicry. Nat Med. 1998;4:781-785
8. Yoon JW, Austin M, OnoDera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979;300:1173-1179
9. Yoon JW, Jun HS. Viruses cause type 1 diabetes in animals. AnnNY Acad Sci. 2006;1079:138-146
10. Rewers M, Zimmet P. The rising tiDe of childhood type 1 diabetes-what is the elusive environmental trigger? Lancet. 2004;364:1645-1647
11. Von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Microbiology. 2003; 1:151-157
12. Lammi N, KarVonen M, Tuomilehto J. Do microbes have a causal role in type 1 diabetes? Med Sci Monit. 2005;11:RA63-RA69
13. Filippi C, Von Herrath M. How viral infections affect the autoimmune process leading to type 1 diabetes. Cell Immunol. 2005;233: 125-132
14. Jun HS, Yoon JW.Anew look at viruses in type 1 diabetes. Diabetes Metab Res Rev. 2003;19:8-31
15. HinDersson M, Maria H, Elshebani A, et al. Simultaneous type 1 diabetes onset in mother and son coinciDent with an enteroviral infection. J Clin Virol. 2005;33:158-167
16. Mkel M, Vaarala O, Hermann R, et al. Enteral virus infections in early childhood and an enhanced type 1 diabetes-Associated antibody response to dietary insulin. J Autoimmun. 2006;27:54-61
17. Jadane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab. 2008;34:537-548
18. Helfand RF, Gary HE Jr, Freeman CY, AnDerson LJ, Pallansch MA. Serologic eviDence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. J Infect Dis. 1995;172:1206-1211
19. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-Analysis of observational molecular studies. BMJ. 2011;342:d35
20. Stene LC, Oikarinen S, Hyty H, et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes. 2010; 59:3174-3180
21. Oikarinen S, Martiskainen M, Tauriainen S, et al. EnterovirusRNA in blood is linked to the Development of type 1 diabetes. Diabetes. 2011;60:276-279
22. King ML, Shaikh A, Bidwell D, Voller A, Banatvala JE. Coxsackie-B-virus-specific IgM responses in children with insulin-DepenDent (juvenile-onset; type I) diabetes mellitus. Lancet. 1983;1:1397-1399
23. Friman G, Fohlman J, Frisk G, et al. An inciDence peak of juvenile diabetes. Relation to Coxsackie B virus immune response. Acta Paediatr Scand Suppl. 1985;320:14-19
24. Ylipaasto P, Klingel K, Lindberg AM, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet cells. Diabetologia. 2004;47:225-239
25. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes. 2000;49:708-711
26. Serreze DV, Wasserfall C, Ottendorfer EW, et al. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and interferon. J Virol. 2005; 79:1045-1052
27. Horwitz MS, Fine C, Ilic A, Sarvetnick N. Requirements for viralmediated autoimmune diabetes:-cell damage and immune infiltration. J Autoimmun. 2001;16:211-217
28. Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and type 1 diabetes Development in NOD mice: insulitis Determines susceptibility of pancreatic islets to virus infection. Virology. 2004;329:381-394
29. Laitinen OH, Honkanen H, Pakkanen O, et al. Coxsackievirus B1 is associated with induction of-cell autoimmunity that portends type 1 diabetes. Diabetes. 2014;63:446-455
30. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranDed RNA and activation of NF-B by toll-like receptor 3. Nature. 2001;413:732-738
31. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2:675-680
32. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004;5:987-995
33. Muzio M, Bosisio D, Polentarutti N, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in Dendritic cells. J Immunol. 2000; 164:5998-6004
34. Heinz S, Haehnel V, Karaghiosoff M, et al. Species-specific regulation of toll-like receptor 3 genes in men and mice. J Biol Chem. 2003;278:21502-21509
35. Wesch D, Beetz S, Oberg HH, Marget M, Krengel K, Kabelitz D. Direct costimulatory effect of TLR3 ligand poly(I:C) on human T lymphocytes. J Immunol. 2006;176:1348-1354
36. Orinska Z, Bulanova E, Budagian V, Metz M, Maurer M, Bulfone-Paus S. TLR3-induced activation of mast cells modulates CD8 T-cell recruitment. Blood. 2005;106:978-987
37. McCall KD, Harii N, Lewis CJ, et al. High basal levels of functional toll-like receptor 3 (TLR3) and noncannonical Wnt5a are expressed in papillary thyroid cancer (PTC) and are coordinately Decreased by phenylmethimazole together with cell proliferation and migration. Endocrinology. 2007;148:4226-4237
38. Harii N, Lewis CJ, Vasko V, et al. Thyrocytes express a functional toll-like receptor 3(TLR3): overexpression can be induced by viral infection, reversed by phenylmethimazole and is associated with Hashimotos autoimmune thyroiditis. Mol Endocrinol. 2005;19: 1231-1250
39. Yang X, Murthy V, Schultz K, Tatro JB, Fitzgerald KA, Beasley D. Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2006;291:H2334-H2343
40. Ciencewicki J, Brighton L, Wu WD, MadDen M, Jaspers I. Diesel exhaust enhances virus-And poly(I:C)-induced toll-like receptor 3 expression and signaling in respiratory epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;290:L1154-L1163
41. Lafon M, Megret F, Lafage M, Prehaud C. The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J Mol Neurosci. 2006;29:185-194
42. Bsibsi M, Ravid R, Gveric D, Van Noort JM. Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002;61:1013-1021
43. Rasschaert J, Ladriere L, Urbain M, et al. Toll-like receptor 3 and STAT-1 contribute to double-stranDedRNAinterferon-induced apoptosis in primary pancreatic-cells. J Biol Chem. 2005;280: 33984-33991
44. Giarratana N, Penna G, Amuchastegui S, Mariani R, Daniel KC, Adorini L. A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes Development. J Immunol. 2004;173: 2280-2287
45. Wen L, Peng J, Li Z, Wong FS. The effect of innate immunity on autoimmune diabetes and the expression of toll-like receptors on pancreatic islets. J Immunol. 2004;172:3173-3180
46. Devendra D, Eisenbarth GS. Interferon-A potential link in the pathogenesis of viral-induced type 1 diabetes and autoimmunity. Clin Immunol. 2004;111:225-233
47. Lang KS, Recher M, Junt T, et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med. 2005;11:138-145
48. Shibasaki S, Imagawa A, Tauriainen S, et al. Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocr J. 2010;57:211-219
49. Miranda-HernanDez S, Baxter AG. Role of toll-like receptors in multiple sclerosis. Am J Clin Exp Immunol. 2013;2:75-93
50. Laska MJ, Troldborg A, Hansen B, et al. Polymorphisms within toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females. Rheumatology. 2014;53:48-55
51. Midgley A, Thorbinson C, Beresford MW. Expression of toll-like receptors and their Detection of nuclear self-Antigen leading to immune activation in JSLE. Rheumatology. 2012;51:824-832
52. Webb SR, Loria RM, Madge GE, Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med. 1976;143:1239-1248
53. Wong FS, Hu C, Zhang L, et al. The role of toll-like receptors 3 and 9 in the Development of autoimmune diabetes inNODmice.AnnNY Acad Sci. 2008;1150:146-148
54. Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S. GroupBcoxsackievirus diabetogenic phenotype correlates with replication efficiency. J Virol. 2006;80:5637-5643
55. Oshiumi H, Okamoto M, Fujii K, et al. The TLR3/TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J Immunol. 2011;187:5320-5327
56. Filippi CM, Estes EA, Oldham JE, Von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest. 2009;119:1515-1523
57. Thivolet C, BenDelac A, Bedossa P, Bach JF, Carnaud C. CD8 T cell homing to the pancreas in the nonobese diabetic mouse isCD4 T cell-DepenDent. J Immunol. 1991;146:85-88
58. Yoon JW, Jun HS. Autoimmune Destruction of pancreatic cells. Am J Ther. 2005;12:580-591
59. Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M. Analysis of the roles of CD4 and CD8 T cells in autoimmune diabetes ofNODmice using transfer toNODathymic nuDe mice. Eur J Immunol. 1992;22:2387-2393
60. Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunoDeficient NOD-scid/scid mice. Relative contributions of CD4 and CD8 T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes. 1993;42:44-55
61. Nagata M, Yoon JW. Studies on autoimmunity for T-cell-mediated-cell Destruction. Distinct difference in-cell Destruction between CD4 and CD8 T-cell clones Derived from lymphocytes infiltrating the islets of NOD mice. Diabetes. 1992;41:998-1008
62. Chen W, Wahl SM. TGF-: the missing link in CD4CD25 regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev. 2003;14:85-89
63. Nakamura K, Kitani A, Strober W. Cell contact-DepenDent immunosuppression by CD4()CD25() regulatory T cells is mediated by cell surface-bound transforming growth factor . J Exp Med. 2001;194:629-644
64. You S, Belghith M, Cobbold S, et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-DepenDent changes in pathogenic T-cells. Diabetes. 2005;54:1415-1422
65. McCall KD, Schmerr MJ, Thuma JR, et al. Phenylmethimazole suppresses dsRNA-induced cytotoxicity and inflammatory cytokines in murine pancreatic cells and blocks viral acceleration of type 1 diabetes in NOD mice. Molecules. 2013;18:3841-3858.